The present invention relates to novel bicyclic thiazoles which are positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (“mGluR5”) and which are useful for the treatment or prevention of disorders associated with glutamate dysfunction and diseases in which the mGluR5 subtype of receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which mGluR5 is involved.
本发明涉及新型的双环
噻唑,它们是代谢型谷
氨酸受体亚型5(“mGluR5”)的阳性别构调节剂,可用于治疗或预防与谷
氨酸功能障碍有关的疾病以及涉及mGluR5受体亚型的疾病。该发明还涉及包含这种化合物的药物组合物,制备这种化合物和组合物的方法,以及利用这种化合物和组合物预防和治疗涉及mGluR5的疾病的用途。